Close menu




July 16th, 2020 | 07:30 CEST

BYD, Commerzbank, Osino Resources - very exciting developments for investors

  • Investments
Photo credits: pixabay.com

Investors around the world are looking for the next opportunity to invest or secure their money. Access to information and the networking of capital and the media are creating increasingly strong trends. "The trend is your friend," says an old stock market saying. But it is always followed by "The devil will take the hindmost." It's getting harder and harder to buy and leave it. The disruption of old business models poses great challenges for conservative investors. Nevertheless, there are exciting developments that offer great opportunities for investors.

time to read: 2 minutes | Author: Mario Hose
ISIN: CNE100000296 , DE000CBK1001 , CA68828L1004

Table of contents:


    Success by script

    The central banks are creating great demand for gold by increasing the money supply. The world's oldest currency has been rising significantly since last year and there is no end in sight. For this reason, the interest in potential new discoveries in the exploration sector is also increasing. Osino Resources has just successfully completed a further round of financing and received CAD 17.7 million in fresh capital. CEO Heye Daun knows his way around and knows what's important. He has already made an exploration company capable of being taken over in 2012 and this is now being repeated with Osino.

    Daun mentions some details in the company's announcement: "This financing is a very important milestone that substantially de-risks the Company and allows us to further expand all of our activities with a view to fast-tracking the timeline to maiden resource, PEA and further project development of the Twin Hills area of the Karibib Gold Project. Osino is now fully funded for expanded exploration and resource drilling and accelerated development studies for Twin Hills. We are also very pleased to have been able to further diversify and strengthen our shareholder base by attracting a range of highly reputable, long-term institutional investors who share our vision of making further discoveries whilst rapidly growing and advancing Osino's existing Namibian projects."

    Successful false start

    The Chinese conglomerate BYD is active in the mobility sector and manufactures batteries in addition to various vehicle models. Due to the Corona Pandemic, however, the sales of vehicles have fallen from 228,000 to 158,600. Nevertheless, the company's shares have been able to complete a rally in recent weeks, which now appears to have slowed down.

    The analysts from DZ Bank started their coverage of BYD and started it with a sell recommendation. They see a price target of HKD 65.00, which is equivalent to a price of EUR 7.35. With a 2021e P/E ratio of 73, the experts currently see no further price potential. Yesterday the share was traded at around EUR 8.90.

    Claims for damages due to Wirecard?

    Commerzbank left the DAX in 2018 and had to give up the field to Wirecard, an up-and-coming Fintech company at the time. The company against which the public prosecutor's office in Munich was already investigating in 2010 and which was discontinued in 2012, as reported by the magazine 'CAPITAL'. As can be seen from the report, the facts of the case were already evident at the time and it could be proven that the company was actively engaged in money laundering via illegal gaming platforms. It should not have had to come so far as it did now. "Why was Wirecard not already vigorously cracked down in 2010?" These are the questions that many damaged parties are currently asking themselves.

    Of particular interest will be the future constellation of Commerzbank as lender to Wirecard and the auditing company EY. EY has certified a large position on Wirecard's balance sheet over many years and thus made creditworthiness possible in the first place, which means that Commerzbank will probably have to make write-downs in the millions. Since 2017, EY has also been Commerzbank's auditor again. Will claims for damages now come into play? Obviously.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by Carsten Mainitz on October 14th, 2026 | 05:30 CEST

    Tungsten, Weapons and Growth: Almonty, Rheinmetall and Deutz Under Review. Is This an Opportunity in a Megatrend?

    • Tungsten
    • Raw materials
    • Critical raw materials
    • Geopolitics
    • Defence industry
    • Armaments
    • Military
    • Supply chains
    • Investments

    The stock market is not linear. Greed and fear, excessive optimism or excessive scepticism—all of these drive markets. Only the future will tell what is cheap or expensive today. The stocks mentioned above are at precisely this point. Secure supply chains, access to raw materials and defence readiness are high on the agenda of Western governments. These long-term trends play strongly into the hands of defence companies and raw material producers. Almonty, in particular, as a producer of the critical raw material tungsten, holds a leading position in the sector. Where do the greatest opportunities lie for investors now?

    Read

    Commented by Carsten Mainitz on October 14th, 2026 | 05:25 CEST

    Who Profits When Patents Expire? The Billion-Euro Race Between Formycon, Fresenius and Pfizer

    • Biosimilar
    • FDA
    • Milestone
    • Cancer therapy
    • Pharma
    • Patents
    • Investments

    When patent protection for high-revenue biopharmaceuticals expires, a billion-euro market for follow-on products emerges. Michael Sen, head of the German healthcare group Fresenius SE, cites an impressive figure. By 2035, this could generate around EUR 180 billion in revenue. In particular, biosimilars, biotechnologically produced follow-on medicines that are highly similar in composition to the original medicine and equivalent in quality, efficacy and safety, are forecast to grow significantly. Moreover, biosimilars can strengthen competition and reduce treatment costs. Formycon stands out as a pure play. The company recently reached a crucial milestone. The US Food and Drug Administration (FDA) accepted the marketing authorisation application, the first publicly known application of its kind, for FYB206, a biosimilar candidate to the cancer medicine Keytruda, for review. Keytruda generates around USD 32 billion in annual revenue, making it the world's highest-revenue medicine. Fresenius is strengthening its positioning in the biosimilar sector through an acquisition. Pfizer needs new growth drivers. Who is best positioned for the year-end rally?

    Read

    Commented by Matthias Schomber on October 12th, 2026 | 05:24 CEST

    Every Crisis Creates an Opportunity: Nordex Stumbles, Jungheinrich Struggles, and RE Royalties Looks to Have Found a Bottom

    • Investments
    • Trading Opportunity
    • Technical Analysis
    • Rebound

    When market participants suddenly lose their nerve, and industrial heavyweights like Jungheinrich plunge to new multi-year lows despite bulging order books, a key question for private investors, among others, is whether this is a dangerous crisis with further downside ahead or an attractive entry opportunity. Nordex, too, has recently struggled to build on its successes from earlier this year. The share is trapped in a consolidation phase and has now returned to its level from late February, when it broke out upwards on high volume and with a long green weekly candlestick. Is this an attractive entry point for investors desperately seeking stable, high-yield alternatives in the future-oriented renewable energy market? Find out why scepticism could prevail regarding well-known German names and why a pioneer in royalty financing could be on the verge of the next major share price surge following a technical “textbook pattern”.

    Read